Clinical Trials Browser

OTHER × Niacinamide × 30 days × Clear all

NCT07286318 2026-06-05

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Phase EARLY_PHASE1 Recruiting

Carcinoma, Basal Cell, Skin Neoplasms, Keratosis, Actinic